BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.13+0.12 (+1.50%)
Close on Nov 17, 2026Market cap $3.26BP/E –Yield –
BGM price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BGM's price to sales ratio was 42.4× on Nov 11, 2026, against 81.9× a year earlier. Over the last 5 years it ranged from 7.6× to 176.2×, with a median of 36.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 42.4× | −53.7 |
| 2025 | Apr 30, 2025 | 96.1× | +23.1 |
| 2024 | Dec 31, 2024 | 73.0× | +55.0 |
| 2023 | Dec 29, 2023 | 18.0× | +5.6 |
| 2022 | Dec 30, 2022 | 12.4× | −37.4 |
| 2021 | Dec 31, 2021 | 49.8× | – |
See a number that looks wrong?